Want to see SPRO full AI Analyst Report?
Spero Therapeutics (SPRO) Q2 2021 Earnings Report
603 Followers
SPRO Q2 2021 EPS Results
- Actual EPS
- -$0.63
- Consensus EPS
- -$0.75
- Beat/Miss
- Beat by +$0.12
- One Year Ago EPS
- -$0.85
SPRO Q2 2021 Revenue Results
- Actual Revenue
- $2.11M
- Expected Revenue
- $4.53M
- Beat/Miss
- Missed by -$2.42M
- YoY Revenue Growth
- +21.95%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/05/2021
- Time
- After Close
- Conference Call
- Thursday, August 5, 2021
SPRO Upcoming Earnings
Spero Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
SPRO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q3) | -0.47- | -0.13 | ― | ― |
| Aug 12, 2026 | 2026 (Q2) | ―-0.16 | -0.03 | -433.33% (-0.13) | |
| May 13, 2026 | 2026 (Q1) | ―-0.13 | -0.25 | 48.00% (+0.12) | |
| Mar 26, 2026 | 2025 (Q4) | -0.200.53 | -0.38 | 239.47% (+0.91) | |
| Nov 13, 2025 | 2025 (Q3) | -0.25-0.13 | -0.32 | 59.38% (+0.19) | |
| Aug 12, 2025 | 2025 (Q2) | -0.38-0.03 | -0.33 | 90.91% (+0.30) | |
| May 13, 2025 | 2025 (Q1) | -0.55-0.25 | -0.24 | -4.17% (-0.01) | |
| Mar 27, 2025 | 2024 (Q4) | -0.31-0.38 | 0.96 | -139.58% (-1.34) | |
| Nov 14, 2024 | 2024 (Q3) | -0.27-0.32 | -0.06 | -433.33% (-0.26) | |
| Aug 05, 2024 | 2024 (Q2) | -0.38-0.33 | -0.23 | -43.48% (-0.10) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
